Anebulo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 22NW, LP | 11/14/2024 | 5.37 M | $10.36 M | 0.00% | 20.69% |
| LVW ADVISORS, LLC | 10/09/2024 | 641,039 | $1.24 M | -0.16% | 2.47% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 511,073 | $986,371 | 0.00% | 1.97% |
| MORGAN STANLEY | 11/14/2024 | 399,219 | $770,493 | 0.00% | 1.54% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 157,862 | $304,675 | 0.00% | 0.61% |
| VANGUARD GROUP INC | 11/13/2024 | 154,036 | $297,289 | 0.11% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 87,790 | $169,474 | 71.10% | 0.34% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 18,978 | $36,628 | 0.00% | 0.07% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3,905 | $7,536 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,694 | $5,199 | -18.36% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 763 | $1,473 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 76 | $147 | 16.92% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 9 | $17 | -10.00% | 0.00% |
Anebulo Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Anebulo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
22NW, LP: 5.37 M
Nantahala Capital Management, LLC: 511,073
MORGAN STANLEY: 399,219
Ikarian Capital, LLC: 157,862
VANGUARD GROUP INC: 154,036
GEODE CAPITAL MANAGEMENT, LLC: 87,790
28.32% of Anebulo Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.71 M shares in the last 24 months. This purchase volume represents approximately $11.20 M in transactions.